Kidney Stone Risk Panel, Urine
Also known as: KID
Use
This test is used to monitor kidney stone formation by measuring calcium, citric acid, creatinine, oxalate, and uric acid in urine. The results can help in managing and preventing nephrolithiasis, also known as kidney stone disease. It provides valuable information about the excretion of these metabolites, which may contribute to stone formation if abnormal.
Special Instructions
The preferred test options for more comprehensive assessment are Supersaturation Profile, Urine (2008771) or Calculi Risk Assessment, Urine (2008708). Specimens should be collected over 24 hours with refrigeration during collection, and transported using the specified urine collection kit.
Limitations
This test was developed and its performance characteristics determined by ARUP Laboratories. However, it has not been cleared or approved by the US Food and Drug Administration. It is performed in a CLIA certified laboratory and is intended for clinical purposes only. Deviations in sample collection time or volume might affect the interpretation, and the test is considered unacceptable if not stored or transported under frozen conditions.
New York Approved
Methodology
Other
Biomarkers
LOINC Codes
- 35675-8
- 6874-2
- 35674-1
- 2162-6
- 3086-6
- 3087-4
- 6687-8
- 2128-7
- 2701-1
- 27222-9
- 19153-6
- 30211-7
Result Turnaround Time
1-6 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
4 mL
Minimum Volume
4 mL
Container
Sulfamic acid tube, sodium carbonate tube, unpreserved tube
Collection Instructions
Collect 24-hour urine. Use ARUP Calculi Risk/Supersaturation Urine Collection Kit.
Patient Preparation
Refrigerate during 24-hour urine collection.
Storage Instructions
Freeze immediately after collection.
Causes for Rejection
Improperly preserved or transported samples, samples not frozen.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | Unacceptable |
| Refrigerated | Unacceptable |
| Frozen | 2 weeks |